| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $142.9M | -22.6% |
| Cost of Revenue | $111.3M | -24.1% |
| Gross Profit | $31.6M | -16.7% |
| R&D Expense | $13.9M | -17.6% |
| SG&A Expense | $21.3M | -41.9% |
| Operating Income | -$27.2M | +41.0% |
| Pre-tax Income | -$42.8M | -158.9% |
| Income Tax | $1.2M | +158.3% |
| Net Income | -$44.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14.1M | -62.7% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $22.9M | -32.5% |
| Current Assets | $40.8M | -62.2% |
| Total Assets | $54.1M | -55.4% |
| Current Liabilities | $37.6M | +20.8% |
| Long-term Debt | $39.9M | -39.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$30.8M | +52.7% |
| Investing Cash Flow | $24.7M | -69.8% |
| Financing Cash Flow | -$18.1M | -225.4% |
| -158.9% |
| EPS (Basic) | -$3.28 | -112.2% |
| EPS (Diluted) | -$3.28 | -112.9% |
| Total Liabilities |
| $85.7M |
| -23.2% |
| Stockholders' Equity | -$31.7M | -429.8% |